CMA will ascertain the majority of PMS cases which most often result from deletions or other structural rearrangements resulting in copy number loss of varying size on 22q13 but will not identify patients with pathogenic SHANK3 variants or smaller intragenic deletions or duplications which disrupt gene function [30]. The gene discussed is SHANK3; the disease is premenstrual tension.